Skip to main content
Fig. 3 | Clinical Epigenetics

Fig. 3

From: Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies

Fig. 3

Prognostic and predictive value of SOX30 methylation in MDS/AML patients. a–f The prognostic value of SOX30 methylation for OS and LFS among AML patients. The survival analysis was performed among different subtypes of AML patients included whole-cohort AML, non-M3-AML, and CN-AML patients. g Dynamic changes of SOX30 methylation level in paired MDS/sAML patients. SOX30 methylation level was examined by RQ-MSP. sAML indicated MDS-derived AML patients. h, i The prognostic value of SOX30 methylation for OS and LFS among MDS patients

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us